Annual EBITDA
-$6.88 M
+$3.87 M+36.02%
December 31, 2023
Summary
- As of February 21, 2025, INVO annual EBITDA is -$6.88 million, with the most recent change of +$3.87 million (+36.02%) on December 31, 2023.
- During the last 3 years, INVO annual EBITDA has fallen by -$1.40 million (-25.63%).
Performance
INVO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$1.10 M
+$547.92 K+33.30%
September 30, 2024
Summary
- As of February 21, 2025, INVO quarterly EBITDA is -$1.10 million, with the most recent change of +$547.92 thousand (+33.30%) on September 30, 2024.
- Over the past year, INVO quarterly EBITDA has increased by +$89.12 thousand (+7.51%).
Performance
INVO Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$5.58 M
-$223.28 K-4.17%
September 30, 2024
Summary
- As of February 21, 2025, INVO TTM EBITDA is -$5.58 million, with the most recent change of -$223.28 thousand (-4.17%) on September 30, 2024.
- Over the past year, INVO TTM EBITDA has increased by +$174.22 thousand (+3.03%).
Performance
INVO TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INVO EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +36.0% | +7.5% | +3.0% |
3 y3 years | -25.6% | +59.4% | +12.4% |
5 y5 years | -161.7% | +59.4% | +12.4% |
INVO EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | +31.8% | +56.3% | -398.5% | +155.2% | +6.9% | +92.2% |
5 y | 5-year | +292.2% | +56.3% | -398.5% | +155.2% | +218.0% | +92.2% |
alltime | all time | -2226.1% | +56.3% | -218.2% | +304.5% | -610.9% | +92.2% |
INVO Bioscience EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$1.10 M(-33.3%) | -$5.58 M(+4.2%) |
Jun 2024 | - | -$1.65 M(+38.7%) | -$5.35 M(-6.9%) |
Mar 2024 | - | -$1.19 M(-28.0%) | -$5.75 M(-16.4%) |
Dec 2023 | -$6.88 M(-36.0%) | -$1.65 M(+88.6%) | -$6.88 M(-13.1%) |
Sep 2023 | - | -$874.00 K(-57.2%) | -$7.92 M(-17.3%) |
Jun 2023 | - | -$2.04 M(-11.8%) | -$9.57 M(-7.3%) |
Mar 2023 | - | -$2.32 M(-13.9%) | -$10.33 M(-3.6%) |
Dec 2022 | -$10.75 M(+106.0%) | -$2.69 M(+6.4%) | -$10.72 M(+39.9%) |
Sep 2022 | - | -$2.53 M(-9.7%) | -$7.66 M(+2.5%) |
Jun 2022 | - | -$2.80 M(+3.7%) | -$7.47 M(+17.4%) |
Mar 2022 | - | -$2.70 M(-834.6%) | -$6.37 M(+22.1%) |
Dec 2021 | -$5.22 M(-4.7%) | $367.60 K(-115.7%) | -$5.22 M(-29.1%) |
Sep 2021 | - | -$2.34 M(+38.2%) | -$7.36 M(+17.2%) |
Jun 2021 | - | -$1.69 M(+9.3%) | -$6.28 M(+11.4%) |
Mar 2021 | - | -$1.55 M(-12.7%) | -$5.64 M(+3.0%) |
Dec 2020 | -$5.48 M(+212.2%) | -$1.77 M(+41.0%) | -$5.48 M(+23.8%) |
Sep 2020 | - | -$1.26 M(+19.4%) | -$4.42 M(+16.8%) |
Jun 2020 | - | -$1.05 M(-24.0%) | -$3.79 M(+35.6%) |
Mar 2020 | - | -$1.39 M(+92.0%) | -$2.79 M(+59.3%) |
Dec 2019 | -$1.75 M(-33.3%) | -$723.00 K(+16.0%) | -$1.75 M(+13.7%) |
Sep 2019 | - | -$623.20 K(+926.7%) | -$1.54 M(+39.2%) |
Jun 2019 | - | -$60.70 K(-82.5%) | -$1.11 M(-60.9%) |
Mar 2019 | - | -$347.10 K(-32.2%) | -$2.84 M(+7.9%) |
Dec 2018 | -$2.63 M(+287.5%) | -$511.90 K(+171.6%) | -$2.63 M(+13.7%) |
Sep 2018 | - | -$188.50 K(-89.5%) | -$2.31 M(+2.0%) |
Jun 2018 | - | -$1.79 M(+1186.3%) | -$2.27 M(+271.6%) |
Mar 2018 | - | -$139.10 K(-28.9%) | -$610.00 K(-10.1%) |
Dec 2017 | -$678.50 K(-67.8%) | -$195.60 K(+36.9%) | -$678.50 K(-9.9%) |
Sep 2017 | - | -$142.90 K(+7.9%) | -$753.20 K(-7.9%) |
Jun 2017 | - | -$132.40 K(-36.2%) | -$817.70 K(-61.7%) |
Mar 2017 | - | -$207.60 K(-23.2%) | -$2.14 M(+1.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2016 | -$2.11 M(-57.2%) | -$270.30 K(+30.3%) | -$2.11 M(+1.7%) |
Sep 2016 | - | -$207.40 K(-85.7%) | -$2.07 M(+4.5%) |
Jun 2016 | - | -$1.45 M(+709.6%) | -$1.98 M(-60.1%) |
Mar 2016 | - | -$179.30 K(-23.9%) | -$4.97 M(+1.0%) |
Dec 2015 | -$4.92 M(+194.7%) | -$235.60 K(+100.7%) | -$4.92 M(+5.0%) |
Sep 2015 | - | -$117.40 K(-97.4%) | -$4.69 M(+2.6%) |
Jun 2015 | - | -$4.44 M(+3303.5%) | -$4.57 M(+3403.5%) |
Mar 2015 | - | -$130.40 K(-33.6%) | -$130.40 K(-79.0%) |
Dec 2014 | -$1.67 M(+139.5%) | - | - |
Dec 2013 | -$697.30 K(+24.1%) | - | - |
Dec 2012 | -$562.00 K(-9.4%) | - | - |
Dec 2011 | -$620.40 K(-291.7%) | -$196.50 K(+189.4%) | -$620.80 K(-6.2%) |
Sep 2011 | - | -$67.90 K(-64.3%) | -$661.50 K(-12.7%) |
Jun 2011 | - | -$190.00 K(+14.2%) | -$757.60 K(+14.4%) |
Mar 2011 | - | -$166.40 K(-29.8%) | -$662.40 K(-253.2%) |
Dec 2010 | $323.60 K(-124.5%) | -$237.20 K(+44.6%) | $432.40 K(-60.4%) |
Sep 2010 | - | -$164.00 K(+73.0%) | $1.09 M(+86.7%) |
Jun 2010 | - | -$94.80 K(-110.2%) | $584.70 K(+134.4%) |
Mar 2010 | - | $928.40 K(+120.0%) | $249.40 K(-118.9%) |
Dec 2009 | -$1.32 M(-28.7%) | $422.00 K(-162.9%) | -$1.32 M(-62.9%) |
Sep 2009 | - | -$670.90 K(+56.0%) | -$3.56 M(+23.2%) |
Jun 2009 | - | -$430.10 K(-33.0%) | -$2.89 M(+5.7%) |
Mar 2009 | - | -$642.20 K(-64.7%) | -$2.74 M(+29.6%) |
Dec 2008 | -$1.85 M(+7375.8%) | -$1.82 M(>+9900.0%) | -$2.11 M(+592.5%) |
Sep 2008 | - | -$100.00(-100.0%) | -$305.10 K(-0.4%) |
Jun 2008 | - | -$274.00 K(+1439.3%) | -$306.30 K(+576.2%) |
Mar 2008 | - | -$17.80 K(+34.8%) | -$45.30 K(+47.6%) |
Dec 2007 | -$24.80 K(+1450.0%) | -$13.20 K(+915.4%) | -$30.70 K(+75.4%) |
Sep 2007 | - | -$1300.00(-90.0%) | -$17.50 K(+8.0%) |
Jun 2007 | - | -$13.00 K(+306.3%) | -$16.20 K(+406.3%) |
Mar 2007 | - | -$3200.00 | -$3200.00 |
Dec 2006 | -$1600.00 | - | - |
FAQ
- What is INVO Bioscience annual EBITDA?
- What is the all time high annual EBITDA for INVO Bioscience?
- What is INVO Bioscience annual EBITDA year-on-year change?
- What is INVO Bioscience quarterly EBITDA?
- What is the all time high quarterly EBITDA for INVO Bioscience?
- What is INVO Bioscience quarterly EBITDA year-on-year change?
- What is INVO Bioscience TTM EBITDA?
- What is the all time high TTM EBITDA for INVO Bioscience?
- What is INVO Bioscience TTM EBITDA year-on-year change?
What is INVO Bioscience annual EBITDA?
The current annual EBITDA of INVO is -$6.88 M
What is the all time high annual EBITDA for INVO Bioscience?
INVO Bioscience all-time high annual EBITDA is $323.60 K
What is INVO Bioscience annual EBITDA year-on-year change?
Over the past year, INVO annual EBITDA has changed by +$3.87 M (+36.02%)
What is INVO Bioscience quarterly EBITDA?
The current quarterly EBITDA of INVO is -$1.10 M
What is the all time high quarterly EBITDA for INVO Bioscience?
INVO Bioscience all-time high quarterly EBITDA is $928.40 K
What is INVO Bioscience quarterly EBITDA year-on-year change?
Over the past year, INVO quarterly EBITDA has changed by +$89.12 K (+7.51%)
What is INVO Bioscience TTM EBITDA?
The current TTM EBITDA of INVO is -$5.58 M
What is the all time high TTM EBITDA for INVO Bioscience?
INVO Bioscience all-time high TTM EBITDA is $1.09 M
What is INVO Bioscience TTM EBITDA year-on-year change?
Over the past year, INVO TTM EBITDA has changed by +$174.22 K (+3.03%)